Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Peer-reviewed

Research Article

Regulation of Porcine Plasmacytoid Dendritic Cells by Cytokines

Abstract

Plasmacytoid dendritic cells (pDC) are the most potent producers of type-I interferon (IFN) and represent the main interferon (IFN)-α source in response to many viruses. Considering the important roles played by type I IFN’s, not only as antiviral effectors but also as potent alarming cytokine of the immune system, we investigated how such responses are regulated by various cytokines. To this end, we stimulated enriched pDC in the presence or absence of particular cytokines with a strong activator, CpG DNA, or a weak activator of pDC, foot-and-mouth disease virus (FMDV). Alternatively, we pre-incubated pDC for 16 h before stimulation. The pro-inflammatory cytokines tested Interleukin (IL)-6, IL17A, tumour necrosis factor (TNF)-α did not influence IFN-α responses except TNF-α, which promoted responses induced by FMDV. The haematopoietic cytokines Fms-related tyrosine kinase 3 ligand (Flt3-L) and granulocyte-macrophage colony-stimulating factor (GM-CSF) had enhancing effects on pDC activation at least in one of the protocols tested. IFN-β and IFN-γ were the most potent at enhancing FMDV-induced IFN-α, up to 10-fold. Interestingly, also the Th2 cytokine IL-4 was an efficient promoter of pDC activity, while IL-10 was the only negative regulator of IFN-α in pDC identified. The cytokines enhancing IFN-α responses also promoted pDC survival in cell culture with the exception of GM-CSF. Taken together this work illustrates how the cytokine network can influence pDC activation, a knowledge of relevance for improving vaccines and therapeutic interventions during virus infections, cancers and autoimmune diseases in which pDC play a role.

Citation: Lannes N, Summerfield A (2013) Regulation of Porcine Plasmacytoid Dendritic Cells by Cytokines. PLoS ONE 8(4): e60893. https://doi.org/10.1371/journal.pone.0060893

Editor: Volker Thiel, Kantonal Hospital St. Gallen, Switzerland

Received: December 7, 2012; Accepted: March 4, 2013; Published: April 8, 2013

Copyright: © 2013 Lannes, Summerfield. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Funding: This present work was supported by EU FP7 project FMD-Disconvac (grant agreement 226556) and 3R Research Foundation Switzerland (project 113-08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing interests: The authors have declared that no competing interests exist.

Introduction

Plasmacytoid dendritic cells (pDC) represent a major source of interferon (IFN)-α/β and are specialized in sensing viruses. They represent 0.1–0.5% of porcine peripheral blood mononuclear cells (PBMC) [1]. Besides their ability to secrete high amount of type-I IFN, pDC can function as antigen presenting cells, promote immunity or alternatively mediate tolerance [2].

Due to the sensitivity of foot and mouth disease virus (FMDV) to type-I IFN in vitro [3] and in vivo [4], pDC may play an important role in early immunity against FMDV. In fact, it has been demonstrated that in vivo IFN-α responses induced during infection of cattle by FMDV are mediated by pDC [5]. However, FMDV, like other non-enveloped viruses, do not efficiently trigger pDC activation, at least in vitro [6], [7].

For human pDC, it has been demonstrated that the level of IFN-α production by pDC is controlled by distinct cytokines [8]. We therefore hypothesized that cytokines could promote the weak pDC responses to FMDV and aimed to characterize the impact of several cytokines secreted by T helper, myeloid and stromal cells on IFN-α responses and pDC survival. Stimulatory effects were found with haematopoietic cytokines, Th1 and Th2 cytokines, type I IFN and only one of the analysed pro-inflammatory cytokines. Anti-inflammatory interleukin (IL)-10 was the only suppressive cytokine identified.

Materials and Methods

Ethics Statement

Bleeding and care of donor pigs was carried out following ethics approval of the animal licence BE26/11 provided by the Canton of Bern, Switzerland.

Enrichment and Detection of pDC Population

Peripheral blood mononuclear cells (PBMC) were isolated from citrated blood of specific pathogen-free pigs kept at our institute using Ficoll Paque (1.077 g/L, Amersham Pharmacia Biotech AG, Dubendorf, Switzerland) density centrifugation [9]. For enrichment of pDC, CD172a+ cells were sorted using either monoclonal antibodies (mAb) 74-22-15A (ATCC, LGC-Promochem, Molsheim, France) or mAb 74-22-15 (hybridoma kindly provided by Dr. A. Saalmüller, Veterinary University, Vienna, Austria), and a magnetic sorting system (MACS; Miltenyi Biotech GmbH, Bergisch-Gladbach, Germany). Following enrichment, pDC, identified as CD4highCD172alow cells by flow cytometry [10], represented 2–5% of all cells. For CD4, mAb PT90A (VMRD, Pullman WA; now available from Washington State University, Pullman, WA, USA) was employed.

Culture of Cells

Baby Hamster Kidney (BHK) 21 cells were grown in Glasgow's minimum essential medium (GMEM, Life Technologies) supplemented with 5% v/v foetal bovine serum (FBS, Biowest, Nuaillé, France) at 37°C, 6% CO2. For the production of virus, the cells were cultured in serum-free conditions. CD172a+ cells were cultured in Dulbecco's modified Eagle's minimal essential medium (DMEM) plus GlutaMAX™-I (GIBCO, Life Technologies, Basel, Switzerland) supplemented with 20 µM of β-mercaptoethanol (Life Technologies) at 39°C and 6% CO2.

Production of Virus

FMDV O UKG 2001 was propagated in BHK-21 cells [11]. In order to avoid heparin-sulfate adaptation of FMDV, the virus was used with a maximum of three passages in BHK-21 cells after isolation from pigs. The viral titres were determined as described [12]. Mock antigen was prepared from uninfected BHK-21 cells in the same manner as FMDV.

Porcine Recombinant Cytokines

The following bioactive porcine cytokines were added to the culture of CD172a+-sorted cells: tumour necrosis factor-α (TNF-α), granulocyte macrophage colony stimulating factor (GM-CSF), fms-like tyrosine kinase receptor-3 ligand (Flt3-L), IL-2, IL-4, IL-6, IFN-α, IFN-β, IFN-γ, IL-10 and IL-17A. The following cytokines were prepared in house: TNF-α [13], GM-CSF [14], Flt3-L [15], IL-4 [16], IFN-α [17] and IFN-β [18] using transient expression in HEK293 cells. IL-2 was kindly provided by Dr. Shigeki Inumaru (National Institute of Animal Health, Ibaraki, Japan). IL-6 and IL-17A were purchased from Kingfisher Biotech Inc. (St Paul, MN, USA). IFN-γ and IL-10 were purchased from R&D Systems (Abingdon, UK). Data on biological activity of the commercial cytokines are published on the webpage of the suppliers.

Stimulation of Enriched pDC

Freshly isolated CD172a+ cells (4×106cells/ml) were stimulated in 100 µl of serum-free medium with FMDV at a multiplicity of infection (MOI) of 5 tissue culture infectious dose50 (TCID50)/cell or 10 µg/ml of CpG D32 (Eurofins, Ebersberg, Germany), in absence or in presence of cytokines. Cytokines were also used in combinations. Supernatants were harvested after 24 h and IFN-α was detected by ELISA [19]. In some experiments, the cells were stimulated 16 h after pre-incubation with the cytokines.

Determination of Apoptosis and Survival of Cells

CD172a+ cells were cultured and stimulated as described, harvested after 16 h or 24 h at 39°C, labelled with AnnexinV- fluorescein isothiocyanate (FITC) (Bender MedSystems, Vienna, Austria), CD172a and CD4 followed by isotype-specific R-phycoerythrin (R-PE) and FITC conjugates (Southern Biotechnology Associates, Birmingham, AL, USA). Cells were analyzed using three-colour flow cytometry. pDC and monocytes/conventional DC (cDC) were gated based on their CD172a/CD4 phenotype. The absolute number of surviving cells was determined by employment of CountBright counting beads (Life Technologies) following the manufacturers instruction, combined with a forward/side scatter gate to exclude cell debris and shrunken dead cells.

Statistical Analysis

Significant differences were determined with SigmaPlot v11 using the Mann-Withney Rank Sum Test for the IFN-α responses and the t-test for the survival. Both tests were performed with a cut-off p-value <0.05.

Results

Cytokines Modulate the Level of IFN-α Produced by Enriched pDC

The first aim was to identify cytokines influencing pDC activation and to determine the dose-response relationship of their effects (Figure 1). From the pro-inflammatory cytokines, TNF-α was the only cytokine which enhanced IFN-α, while IL-6 and IL-17A had no effect. However, only responses to FMDV were enhanced by TNF-α. The hematopoietic factors GM-CSF and Flt3-L, promoted IFN-α secretion. Interestingly, both classical Th1 and Th2 cytokines, IFN-γ and IL-4 respectively, also had a positive effect on IFN-α secretion. Finally, only the anti-inflammatory cytokine IL-10 was inhibitory for pDC–derived IFN-α production (Figure 1). Our results also demonstrate that relatively high cytokine concentrations of at least 10 ng/ml or 100 U/ml were required to influence IFN-α responses by pDC.

thumbnail
Download:
Figure 1. Cytokines influence the level of IFN-α production by enriched pDC in a concentration dependent manner.

IFN-α responses of CD172a+-sorted cells stimulated with CpG (10 µg/ml; grey line) or FMDV (MOI of 5 TCID50/cell; black line) for 24 h in presence of cytokines at indicated concentration. After stimulation, supernatants were collected and IFN-α was measured by ELISA. The marker represents the mean value of 2 independent experiments with each condition performed in triplicate cultures. The error bar represents the standard deviation.

https://doi.org/10.1371/journal.pone.0060893.g001

We further evaluated selected cytokines using concentrations of 10 ng/ml or 100 U/ml and stimulation of at least three independent cell preparations from 3 different pigs. As illustrated in Figure 2A and 2C, again, Flt3-L, IL-4, IFN-β and IFN-γ promoted a potent enhancement of the level of IFN-α-produced by enriched pDC stimulated with both CpG and FMDV. GM-CSF enhanced and IL-10 inhibited the IFN-α production upon stimulation with CpG but not FMDV. Nevertheless, considering the very low responses induced by FMDV stimulation, inhibitory effects of cytokines are difficult to measure in this model.

thumbnail
Download:
Figure 2. Boxplots showing the statistical analysis for the influence of cytokines on IFN-α production induced by CpG or FMDV in enriched pDC.

Cells were cultured in presence of GM-CSF (100 U/ml), Flt3-L (100 U/ml), IFN-β (100 U/ml), IFN-γ (10 ng/ml), IL-4 (100 U/ml) or IL-10 (10 ng/ml), and either directly stimulated for 24 h (grey bars, A, C) or pre-incubated for 16 h before stimulation with CpG or FMDV for another 24 h (white bars, B, D). IFN-α in the supernatants was measured by ELISA. Values are shown as box plots representing at least 3 independent experiments with each condition performed in triplicate cultures. The black line represents the median value and the red line the mean value. The error bars represent the standard deviation. The asterisk indicates statistical significance between non-treated and treated cells (Mann-Withney Rank Sum test, P<0.05).

https://doi.org/10.1371/journal.pone.0060893.g002

Pre-incubation Modifies the Influence of Cytokines on IFN-α Responses of pDC

With the idea to have an even stronger effect of cytokines on pDC, we tested the impact of pre-incubation of the enriched pDC with the selected cytokines 16 h prior to their stimulation by CpG or FMDV. Surprisingly, when cells were pre-incubated in medium without cytokine and subsequently stimulated, similar levels of IFN-α as freshly stimulated cells were observed in response to CpG (Figure 2A and 2B). However, the treatment resulted in unresponsiveness to FMDV (Figure 2C and 2D). Using this protocol, Flt3-L was the only cytokine able to enhance the level of IFN-α production upon both CpG and FMDV stimulation. IFN-β and IFN-γ increased the level of IFN-α production of CpG-stimulated cells but not of FMDV-stimulated cells. IL-10 inhibited FMDV but not CpG-stimulated cells responses (Figure 2B and 2D).

Synergistic Effects of IFN’s and Other Cytokines on IFN-α Responses

Overall, the above results show that IFN-β and IFN-γ were among the most potent cytokines enhancing pDC activation. We were next interested to determine whether synergistic activities between the IFN’s and the other cytokines were identifiable. Combinations of IFN-β or IFN-γ with GM-CSF, Flt3-L, and IL-4 enhanced the level of IFN-α production by CD172a+ cells in response to CpG, when compared to the IFN’s alone (Figure 3A). Different results were obtained with FMDV-stimulated pDC for which no synergistic activities in terms of enhancement of pDC responses were identified. Nevertheless, combinations of both IFNs with IL-10 inhibited the IFN-α production compared to the corresponding IFN control (Figure 3C). In fact, IL-10 efficiently counteracted the influence of the promoting IFNs and reduced it to the level found with untreated cells stimulated with either CpG or FMDV (data not shown).

thumbnail
Download:
Figure 3. Synergistic effects of IFNs with other cytokines on IFN-α by enriched pDC.

IFN-α responses of CD172a+-sorted cells stimulated with CpG or FMDV in presence of cytokine combined with type-I and II IFN are shown. The effects of IFN-β or IFN-γ in combination with GM-CSF, Flt3-L, IL-3, IL-4 or IL-10 using concentrations as in Figure 2 were tested. Cells were either directly stimulated for 24 h (grey bars, A, C) or pre-incubated for 16 h before stimulation with CpG or FMDV for another 24 h (white bars, B, D). After stimulation, supernatants were collected and IFN-α was measured by ELISA. Values are shown as box plots representing at least 3 independent experiments with each condition performed in triplicate cultures. The black line represents the median value and the red line the mean value. The error bars represent the standard deviation. The asterisk indicates statistical significance between non-treated and treated cells (Mann-Withney Rank Sum test, P<0.05).

https://doi.org/10.1371/journal.pone.0060893.g003

We next evaluated the impact of cytokines combinations when pre-incubated with the enriched pDC prior to stimulation. Combinations of IFN-β or IFN-γ with Flt3-L were able to enhance the IFN-α level of CpG-stimulated cells. In contrast, combinations of both IFNs with IL-10 inhibited the IFN-α production by CpG-stimulated cells. Combinations of both IFNs with GM-CSF did not enhance the IFN-α production upon CpG stimulation (Figure 3B). With FMDV, pre-incubation of the cells for 16 h before stimulation resulted in a lack of response or an overall lower IFN-α production. Only the IFN-β/Flt3-L, the IFN-β/GM-CSF, the IFN-γ/Flt3L and the IFN-γ/IL-4 combination enhanced the level of IFN-α production compared to IFN alone (Figure 3D).

Apoptosis and Survival of pDC

Considering the influence of cytokines on IFN-α response by pDC, we were interested to relate this to apoptosis and survival of pDC. As shown in Figure 4A, a gate on FSChigh/SSChigh cells was combined with a gate on CD4highCD172a+ cells, to identify pDC and on CD4−CD172a+ cells for monocytes and cDC [1]. These populations did not contain many AnnexinV+ cells. However, after including the FSClowSSChigh cells in the gate, a high level of AnnexinV+ CD172a+CD4− monocytes/cDC was found (Figure 4A). Backgating confirmed that the FSClowSSChigh contained the apoptotic monocytes/cDC, which had a reduced CD172a expression (data not shown). For the pDC defined as CD4highCD172a+ population only a minor fraction was identify as AnnexinV+. However, it appeared that apoptotic pDC have reduced CD4 and possibly also CD172a expression making their identification problematic. In fact, as shown in Fig. 4B, the CD4highCD172a+ population almost completely disappeared after CpG stimulation. We concluded that the most accurate way to determine survival was by assessing the absolute numbers of AnnexinV- cells among the FSChigh/SSChigh cells in the phenotypic gates defined in Figure 4A. This analysis confirmed that CpG stimulation depleted pDC while enhancing the number of monocytes/cDC. FMDV neither influenced the survival of pDC nor monocytes/cDC in a statistically significant manner (Figure 4C and 4D).

thumbnail
Download:
Figure 4. CpG but not FMDV deplete pDC population by inducing apoptosis.

CD172a+ sorted cells were untreated (A) or stimulated with 10 µg/ml of CpG for 16 h or FMDV for 24 h (B, C, D). A. Three-color FCM of CD4, CD172a and AnnexinV, with a CD4/CD172a dot plot defining the pDC gate (CD4highCD172alow) and the monocyte/cDC gate (CD4−CD172a+) after culture in medium. On the left side plot, putative live cells and live and dead cells were defined according to the FSC/SSC profile, excluding lymphocytes and cell debris. On the right side plots, the AnnexinV expression of the gated pDC (blue) and monocytes/cDC (red) with percentages are shown. B. Apoptosis of pDC and monocytes/cDC after stimulation with CpG, Mock antigen and FMDV. On the left side plot, pDC and monocytes/cDC with percentages were gated on live/dead cells as described in A. On the right side plot, the AnnexinV expression of the gated cell populations with percentages is shown after CpG or FMDV stimulation. C, D. Absolute number of pDC and monocytes/cDC on gated live cells after culture of enriched pDC with CpG, FMDV or only medium. Each marker represents results from one individual experiment and the bar represents the mean value. The asterisk indicates statistical significance between treated and non-treated cells (t-test, P<0.05).

https://doi.org/10.1371/journal.pone.0060893.g004

We next applied these analyses to determine the impact of cytokines on survival of pDC and monocytes. In Figure 5A, the CD172a/CD4 dot plots give a visual impression on the effects of the cytokines, while Figure 5B and C give the absolute numbers. Flt3-L, type I IFN and IL-4 induced the survival of pDC, and IFN-γ promoted both pDC and monocytes/cDC survival. GM-CSF only promoted the survival of monocytes/cDC (Figure 5B and 5C). Altogether, these results demonstrate that the cytokines enhancing IFN-α responses often but not always promote pDC survival.

thumbnail
Download:
Figure 5. Impact of cytokines on pDC and monocytes survival.

Enriched pDC were cultured in presence of the indicated cytokines (concentrations as defined in Figure 2) for 16 h at 39°C. In A, the frequencies of pDC (blue) and monocytes/cDC (red) are shown on gated live cells. The plots are of a representative animal. In B and C, the survival of pDC and monocytes/cDC was determined on live cells. Each marker represents one individual culture of on animal and the bar the mean value. The asterisk indicates statistical significance between treated and non-treated cells (t-test, P<0.05).

https://doi.org/10.1371/journal.pone.0060893.g005

Discussion

The present study confirms and elaborates on the important impact of cytokines on pDC activation and survival. High level of IFN-α production did not always relate to the high number of surviving pDC indicating that other factors such as priming effects are mediating the effects. An example for this are the known effects of type I IFNs on the expression of IRF7 [20], a key transcription factor for IFN-α [21]. We also demonstrated that the effect of cytokines is not identical when CpG is compared to FMDV stimulation. This is not surprising, considering that cytokines may modulate pDC elements, which indirectly influence IFN-α responses such as uptake receptors or the antiviral status of the cells. For example, entry of FMDV requires specific integrins at the cell surface [22] while CpG utilizes a multilectine receptor, DEC-205 [23]. It is also possible that the differences are caused by the fact that pDC respond to CpG via toll-like receptor (TLR)9 [19] and FMDV via TLR7 [7]. Compared to CpG, FMDV is a very inefficient stimulator of pDC even in the presence of promoting cytokines. There are several possible explanations for this. First, the virus seems inefficient in attaching and entering pDC, and this can be improved by complexing it with specific antibodies which promote FcγRII-mediated uptake [6]. We know from previous work that pDC activation by FMDV is not influenced by cell culture adaptation to heparin sulphate receptors [7]. Second, after endocytosis of FMDV by pDC viral RNA might by delivered mostly to the cytosol. As FMDV cannot efficiently replicate in pDC, little RNA will be available for TLR7 triggering. Third, viral inhibitors of the IFN system such as Lpro [24] might prevent pDC activation. Future studies are required to address this issue but it appears that in vivo pDC are activated by FMDV, resulting in a transient early systemic IFN-α response [5], [25], indicating that pDC represent a relevant cell type during FMDV infection.

In general terms, our study support the concept that pDC are regulated at various steps of the innate and adaptive immune response by the cytokine network. The inflammatory cytokines tested were not able to promote activation of pDC with the exception of TNF-α, which enhanced the levels of IFN-α in response to FMDV but not CpG. A possible explanation for this could be antiviral effects controlling the level of viral proteins known to interfere with the IFN system such as Lpro of FMDV [24]. The observation that IL-17A did not influence pDC responses would relate to the fact that this cytokine is typically associated with bacterial infections [26] for which strong pDC responses are less relevant. It is also understandable that during strong inflammatory cytokine responses often associated with tissue damage an additional potentiation of IFN-α responses could be detrimental.

In contrast, the two hematopoietic cytokines tested (GM-CSF and Flt3L) were able to enhance pDC responses. Stromal cells are the major source of Flt3-L, which is the key cytokine in pDC development [27]. Its receptor (Flt3) is also expressed on differentiated porcine pDC [15] and this is related to the capacity of Flt3-L to enhance pDC activation and survival. Surprisingly, GM-CSF also promoted pDC activation (by CpG only) although our previous study demonstrated a lack of GM-CSF receptors on pDC [10]. A possible explanation could be that GM-CSF acts indirectly via promoting monocyte survival and activation, which in turn support pDC. This needs further clarification by using pure pDC populations in future studies.

Type-I IFNs possess antiviral activity and stimulate their own production allowing the release of high levels of IFN-α via a positive feed-back loop mechanism [28]. This is also functional in pDC [20], [21], [28]. Type I IFNs promote porcine pDC survival (this study) and also efficiently prime pDC by inducing high levels of IRF7 [20]. We think that for these reasons IFN-β was the most potent enhancer of IFN-α responses when all experimental conditions employed in the present study are considered.

The final group of cytokines investigated were classical Th1 and Th2 cytokines. This was considered important knowing the homing characteristics of pDC to the T-cell area in the activated lymph nodes [29]. Interestingly, both IFN-γ the major Th1 and IL-4 the major Th2 cytokine promoted pDC activation and survival. This indicates that the Th1/Th2 system does not imprint a particular bias on pDC but rather supports their function during a T-cell response. Nevertheless, it should be noted that porcine IL-4 has been reported to functionally differ from human and mouse IL-4 at least with respect to its ability to promote B-cell activation and this author has questioned the role of IL-4 in the porcine Th1-Th2 paradigm [30]. Furthermore, IL-4 has been difficult to detect, both at the protein and mRNA level, in vitro and in vivo [30]. It is possible that in particular breeds of pigs IL-13 could have a more prominent role for porcine Th2 responses [31]. On the other hand, both IL-4 and IL-13 are able to induce the generation of monocytes-derived DC in the pig [32] and to prevent apoptosis of endothelial cells [33]. Independent of this issue requiring further clarification, pDC are more likely to promote Th1 responses through secretion of type I IFNs, IL-12 and TNF-α [2]. We and others have also found this profile of cytokines for porcine pDC [1], [34].

As expected from studies with other species [8], the anti-inflammatory cytokine IL-10 represents a main negative regulator of porcine pDC. This cytokine is produced by regulatory T cells, and many other cells such as monocytes/macrophages, B cells and DC during the terminal phase of an immune response, where it has important anti-inflammatory functions to prevent unnecessary tissue damage caused by the immune system. Interestingly, pDC have been reported to control B-cell-derived IL-10 production [35], which together with the strong effects of IL-10 on pDC activation would fit into the concept of a vicious circle of chronic pDC activation such as described during systemic lupus erythemathosus [36]. Considering the necessity to regulate innate immune responses to avoid damaging effects of IFN-α during infections, it is not surprising that other cytokines such as include prostaglandin E2 and transforming growth factor-β [37]-[41] which counter-regulate pDC responses have been described. Their effect on porcine pDC was not addressed in the present study, but we expect a suppression of IFN-α responses as in other species.

Taken together, the knowledge on how cytokines regulate pDC responses can be employed to modulate the immune response towards a wanted direction. Considering the importance of type-I IFN as endogenous immunological adjuvant, cytokines could for instance be used to enhance pDC-derived type-I IFN during vaccination. Another area would be to employ such knowledge for immunotherapies of cancer, chronic virus infections and autoimmune diseases where pDC responses can be beneficial or unwanted.

Acknowledgments

We thank Heidi Gerber for mAb preparation and Sylvie Python for cytokines preparation as well as Andreas Michel and Hans-Peter Lüthi for regular bleeding and care of the animals.

Author Contributions

Conceived and designed the experiments: NL AS. Performed the experiments: NL. Analyzed the data: NL AS. Contributed reagents/materials/analysis tools: NL AS. Wrote the paper: NL AS.

References

  1. 1. Summerfield A, McCullough KC (2009) The porcine dendritic cell family. Dev Comp Immunol 33: 299–309.
  2. 2. Liu YJ (2005) IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol 23: 275–306.
  3. 3. Chinsangaram J, Koster M, Grubman MJ (2001) Inhibition of L-deleted foot-and-mouth disease virus replication by alpha/beta interferon involves double-stranded RNA-dependent protein kinase. JVirol 75: 5498–5503.
  4. 4. Chinsangaram J, Moraes MP, Koster M, Grubman MJ (2003) Novel viral disease control strategy: adenovirus expressing alpha interferon rapidly protects swine from foot-and-mouth disease. JVirol 77: 1621–1625.
  5. 5. Reid E, Juleff N, Gubbins S, Prentice H, Seago J, et al. (2011) Bovine plasmacytoid dendritic cells are the major source of type I interferon in response to foot-and-mouth disease virus in vitro and in vivo. J Virol 85: 4297–4308.
  6. 6. Guzylack-Piriou L, Bergamin F, Gerber M, McCullough KC, Summerfield A (2006) Plasmacytoid dendritic cell activation by foot-and-mouth disease virus requires immune complexes. Eur J Immunol 36: 1674–1683.
  7. 7. Lannes N, Python S, Summerfield A (2012) Interplay of foot-and-mouth disease virus, antibodies and plasmacytoid dendritic cells: virus opsonization under non-neutralizing conditions results in enhanced interferon-alpha responses. Vet Res 43: 64.
  8. 8. Gary-Gouy H, Lebon P, Dalloul AH (2002) Type I interferon production by plasmacytoid dendritic cells and monocytes is triggered by viruses, but the level of production is controlled by distinct cytokines. J Interferon Cytokine Res 22: 653–659.
  9. 9. McCullough KC, Basta S, Knotig S, Gerber H, Schaffner R, et al. (1999) Intermediate stages in monocyte-macrophage differentiation modulate phenotype and susceptibility to virus infection. Immunology 98: 203–212.
  10. 10. Summerfield A, Guzylack-Piriou L, Schaub A, Carrasco CP, Tache V, et al. (2003) Porcine peripheral blood dendritic cells and natural interferon-producing cells. Immunology 110: 440–449.
  11. 11. McCullough KC, Butcher R (1982) Monoclonal antibodies against foot-and-mouth disease virus 146S and 12S particles. Arch Virol 74: 1–9.
  12. 12. McCullough KC, Parkinson D, Crowther JR (1988) Opsonization-enhanced phagocytosis of foot-and-mouth disease virus. Immunology 65: 187–191.
  13. 13. Von Niederhausern B, Bertoni G, Hertig C, Pfister H, Peterhans E, et al. (1993) Cloning and expression in mammalian cells of porcine tumor necrosis factor alpha: examination of biological properties. Vet Immunol Immunopathol 38: 57–74.
  14. 14. Summerfield A, Horn MP, Lozano G, Carrasco CP, Atze K, et al. (2003) C-kit positive porcine bone marrow progenitor cells identified and enriched using recombinant stem cell factor. JImmunolMethods 280: 113–123.
  15. 15. Guzylack-Piriou L, Alves MP, McCullough KC, Summerfield A (2010) Porcine Flt3 ligand and its receptor: generation of dendritic cells and identification of a new marker for porcine dendritic cells. Dev Comp Immunol 34: 455–464.
  16. 16. Carrasco CP, Rigden RC, Schaffner R, Gerber H, Neuhaus V, et al. (2001) Porcine dendritic cells generated in vitro: morphological, phenotypic and functional properties. Immunology 104: 175–184.
  17. 17. Balmelli C, Ruggli N, McCullough K, Summerfield A (2005) Fibrocytes are potent stimulators of anti-virus cytotoxic T cells. JLeukocBiol 77: 923–933.
  18. 18. Husser L, Alves MP, Ruggli N, Summerfield A (2011) Identification of the role of RIG-I, MDA-5 and TLR3 in sensing RNA viruses in porcine epithelial cells using lentivirus-driven RNA interference. Virus Res 159: 9–16.
  19. 19. Guzylack-Piriou L, Balmelli C, McCullough KC, Summerfield A (2004) Type-A CpG oligonucleotides activate exclusively porcine natural interferon-producing cells to secrete interferon-alpha, tumour necrosis factor-alpha and interleukin-12. Immunology 112: 28–37.
  20. 20. Fiebach AR, Guzylack-Piriou L, Python S, Summerfield A, Ruggli N (2011) Classical Swine Fever virus npro limits type I interferon induction in plasmacytoid dendritic cells by interacting with interferon regulatory factor 7. J Virol 85: 8002–8011.
  21. 21. Honda K, Yanai H, Negishi H, Asagiri M, Sato M, et al. (2005) IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434: 772–777.
  22. 22. Grubman MJ, Baxt B (2004) Foot-and-mouth disease. ClinMicrobiolRev 17: 465–493.
  23. 23. Lahoud MH, Ahmet F, Zhang JG, Meuter S, Policheni AN, et al. (2012) DEC-205 is a cell surface receptor for CpG oligonucleotides. Proc Natl Acad Sci U S A 109: 16270–16275.
  24. 24. Wang D, Fang L, Li P, Sun L, Fan J, et al. (2011) The leader proteinase of foot-and-mouth disease virus negatively regulates the type I interferon pathway by acting as a viral deubiquitinase. J Virol 85: 3758–3766.
  25. 25. Nfon CK, Toka FN, Kenney M, Pacheco JM, Golde WT (2010) Loss of plasmacytoid dendritic cell function coincides with lymphopenia and viremia during foot-and-mouth disease virus infection. Viral Immunol 23: 29–41.
  26. 26. Nishimori JH, Newman TN, Oppong GO, Rapsinski GJ, Yen JH, et al.. (2012) Microbial amyloids induce IL-17A/IL-22 responses via Toll-like Receptor 2 activation in the intestinal mucosa. Infect Immun.
    • 27. Onai N, Obata-Onai A, Schmid MA, Manz MG (2007) Flt3 in regulation of type I interferon-producing cell and dendritic cell development. Ann N Y Acad Sci 1106: 253–261.
    • 28. Sato M, Hata N, Asagiri M, Nakaya T, Taniguchi T, et al. (1998) Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7. FEBS Lett 441: 106–110.
    • 29. Colonna M, Trinchieri G, Liu YJ (2004) Plasmacytoid dendritic cells in immunity. Nat Immunol 5: 1219–1226.
    • 30. Murtaugh MP, Johnson CR, Xiao Z, Scamurra RW, Zhou Y (2009) Species specialization in cytokine biology: is interleukin-4 central to the T(H)1-T(H)2 paradigm in swine? Dev Comp Immunol 33: 344–352.
    • 31. Raymond CR, Wilkie BN (2004) Th-1/Th-2 type cytokine profiles of pig T-cells cultured with antigen-treated monocyte-derived dendritic cells. Vaccine 22: 1016–1023.
    • 32. Bautista EM, Nfon C, Ferman GS, Golde WT (2007) IL-13 replaces IL-4 in development of monocyte derived dendritic cells (MoDC) of swine. Vet Immunol Immunopathol 115: 56–67.
    • 33. Grehan JF, Levay-Young BK, Fogelson JL, Francois-Bongarcon V, Benson BA, et al. (2005) IL-4 and IL-13 induce protection of porcine endothelial cells from killing by human complement and from apoptosis through activation of a phosphatidylinositide 3-kinase/Akt pathway. J Immunol 175: 1903–1910.
    • 34. Calzada-Nova G, Schnitzlein W, Husmann R, Zuckermann FA (2010) Characterization of the cytokine and maturation responses of pure populations of porcine plasmacytoid dendritic cells to porcine viruses and toll-like receptor agonists. Vet Immunol Immunopathol 135: 20–33.
    • 35. Georg P, Bekeredjian-Ding I (2012) Plasmacytoid dendritic cells control B cell-derived IL-10 production. Autoimmunity.
      • 36. Ronnblom L, Alm GV (2001) A pivotal role for the natural interferon alpha-producing cells (plasmacytoid dendritic cells) in the pathogenesis of lupus. J Exp Med 194: F59–63.
      • 37. Son Y, Ito T, Ozaki Y, Tanijiri T, Yokoi T, et al. (2006) Prostaglandin E2 is a negative regulator on human plasmacytoid dendritic cells. Immunology 119: 36–42.
      • 38. Bekeredjian-Ding I, Schafer M, Hartmann E, Pries R, Parcina M, et al. (2009) Tumour-derived prostaglandin E and transforming growth factor-beta synergize to inhibit plasmacytoid dendritic cell-derived interferon-alpha. Immunology 128: 439–450.
      • 39. Contractor N, Louten J, Kim L, Biron CA, Kelsall BL (2007) Cutting edge: Peyer's patch plasmacytoid dendritic cells (pDCs) produce low levels of type I interferons: possible role for IL-10, TGFbeta, and prostaglandin E2 in conditioning a unique mucosal pDC phenotype. J Immunol 179: 2690–2694.
      • 40. Fabricius D, Neubauer M, Mandel B, Schutz C, Viardot A, et al. (2010) Prostaglandin E2 inhibits IFN-alpha secretion and Th1 costimulation by human plasmacytoid dendritic cells via E-prostanoid 2 and E-prostanoid 4 receptor engagement. J Immunol 184: 677–684.
      • 41. Li L, Liu S, Zhang T, Pan W, Yang X, et al. (2008) Splenic stromal microenvironment negatively regulates virus-activated plasmacytoid dendritic cells through TGF-beta. J Immunol 180: 2951–2956.